Multiplex ion beam imaging (MIBI) and imaging mass cytometry (IMC) enable highly multiplexed antibody (40+) staining of frozen or formalin fixed, paraffin-embedded (FFPE) human or murine tissues through detection of metal ions liberated from primary antibodies by time-of-flight mass spectrometry (TOF). These methods make detection of more than 50 targets theoretically possible while maintaining spatial orientation. As such, they are ideal tools to identify the multiple immune, epithelial, and stromal cell subsets in the tumor microenvironment and to characterize spatial relationships and tumor-immune status in either murine models or human samples. This chapter summarizes methods for antibody conjugation and validation, staining, and preliminary data collection using IMC or MIBI in both human and mouse pancreatic adenocarcinoma samples. These protocols are intended to facilitate use of these complex platforms in not only tissue-based tumor immunology studies but also tissue-based oncology or immunology studies more broadly.
Keywords: Frozen or formalin fixed, Paraffin-embedded (FFPE) tissues; Genetically engineered mouse models (GEMM); Imaging mass cytometry (IMC); Metal-conjugated antibodies (MCA); Multiplex ion beam imaging (MIBI); Multiplexing; Pancreatic adenocarcinoma (PDAC); Regions of interest (ROI); Tumor microenvironment (TME).
© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.